您是不是想访问中文网站 ? 点击跳转

BONA presents disposable intranasal atomization device

BONA Pharma has developed an atomizing device for drug administration intended to convert liquid formulations into atomized particles to be sprayed on the surface of human body tissues or organs, meaning it provides full contact and maximizes its application capabilities. Moreover, the carefully designed self-destructive structure ensures the product can only be used once to

BONA is well prepared to develop nasal pump for both originator and generics

After the new automated factory was put into operation in 2019, BONA grows increasingly rapid. In the past years, we had not only upgraded the production lines, but also improved our Quality Management system. Moreover, huge invest in R&D makes BONA products perfect for customers. With the introduction of spray performance analytical devices, our engineers

Renewal-audition for ISO 15378

After 5 days of renewal-audition for ISO 15378 by SGS, we finally get the approval result. This audition started from June 6 and ended on June 10. This time, the SGS auditors gave full affirmation to thecontinuous improvement of BONA quality management system in recent years. We are very happy to share our latest results

Published
Categorized as News

Nasal Drug Delivery-Spray Characterization Tests

Nasal Drug Delivery A look at best practices for testing nasal drug delivery devices Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC  01.25.2019 Nasal spray devices are used to deliver both locally and systemically acting pharmaceutical products,1 and are readily available in the marketplace in unit dose and metered multi-dose formats. Unit